Smart Valor: Switzerland on the Way to Becoming a Leading Hub for Blockchain Innovation
Switzerland’s Economic Minister, Johann Schneider-Ammann, announced last month that the nation’s focus on crypto should move beyond the Crypto Valley and should now refer to the entire country as a ‘Crypto Nation’. This was a demonstration of commitment from the highest political level for the establishment of the crypto industry in Switzerland.
Last week, this was indirectly confirmed in the form of ICO (Initial Coin Offering) guidelines published by Swiss Financial Regulator, FINMA. It represents one of the first frameworks published by a national financial regulator with the goal of giving guidance to startups and companies around conducting compliant crowdfunding.
This topic will be the leading theme of the 2nd annual Crypto Summit, the largest international conference dedicated to blockchain technology in Switzerland. The Crypto Summit will be held on 27-28th March at Samsung Hall in Zurich. Overall, this event is set to bring together leading figures in the global crypto community including Vinny Lingham (CEO of Civic), Alex Tapscott (CEO NextBlock Global), Kathleen Breitman (CEO Tezos), Tim Draper (a venture investor), Jon Matonis (Founding Director of Bitcoin Foundation) and Ransu Salovaara (CEO of TokenMarket).
Vinny Lingham, Silicon Valley based entrepreneur and CEO of Civic, whose popularity rankings recently made him one of the top 5 people in the blockchain industry worldwide, says "I see a growing need for the establishment of specialized crypto hubs with a recognized regulatory environment and global exposure. Switzerland seems to be on its way to becoming such a hub and I am excited to contribute to it,” says Vinny.
Confirming this stance, several high level officials such as Joerg Gasser, State Secretary for International Financial Matters at the Federal Department of Finance and Parliament Member Ruedi Noser, the driving force behind Swiss innovation and startup support, will also join the conference.
“Being held in Switzerland, the epicentre of blockchain and ICOs, the purpose of this event is to bring together Swiss policy makers, global influencers, investors and startups. This is the best way to have to an open dialog, create impact and shape the future together” says Olga Feldmeier, CEO of SMART VALOR and producer of the Crypto Summit.
This year the Crypto Summit will expand on the previous event’s colourful programme of workshops, keynotes and panel discussions. The conference will also include two new tracks: the Crypto Investment Track and the Tech Track. This year’s summit is set to bring together some of the biggest names in crypto to share their experience and best practices for successful crypto investments and ICO execution, including a keynote from blockchain expert Alex Tapscott.
Tapscott is CEO and founder of NextBlock Global, an investment company in the blockchain industry - and co-founder of the Blockchain Research Institute. He and his father, Wikinomics author Don Tapscott, co-wrote the bestselling book ‘Blockchain Revolution: How the Technology Behind Bitcoin is Changing Money, Business and the World’.
With a keynote titled ‘Global State of Crypto’, Tapscott will be sharing his insights about the trends, opportunities and challenges facing the crypto world right now - and speculating on how the industry might evolve in the near future.
“Switzerland has done a good job of providing regulatory clarity to companies, entrepreneurs and foundations while also not restricting their ability to innovate and iterate,” said Tapscott. “As a result, Switzerland is now a leading hub for this fast moving industry. Other governments should take note and heed this example - get regulations right and create a hospitable environment - and you too can lead in the 2nd era of the internet.”
Last year this event became the first international blockchain conference in Switzerland, with 85% of speakers coming from outside of Switzerland and over 30 countries represented among attendees. The keynote was delivered by William Mougayar, one of the key thought leaders in the crypto financing field. This years edition devoted to the theme “Shaping crypto together” is currently open for speaker and sponsor registration.
-- ENDS --
NOTES TO EDITORS:
About SMART VALOR:
SMART VALOR is a Swiss-based company building a decentralized marketplace for tokenized alternative investments. Its mission is to leverage tokenization and cryptocurrencies to democratize access to wealth. For more information, please visit www.smartvalor.com.
Clarity PR for Smart Valor
+44 (0) 20 7100 1333
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on